1H-Furo[3,2-C]Pyrazoles active as aurora kinase inhibitors

摘要

Furo[3,2-c]pyrazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention can be useful, in therapy, in the treatment of disorder or conditions associated with an altered Aurora kinase activity, such as cancer.